Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
We’ve developed a wealth of materials on the growing scourge of antimicrobial resistance. The papers, policy briefs and other background materials found on this page can be used by policymakers, researchers, advocates, healthcare workers and others to inform and develop the response to an issue that the World Health Organization has described as one of the top 10 global health threats.
This report by Health Action International and the PHG Foundation focuses on the use of diagnostic tests that can be used to characterise a patient’s infection to inform antimicrobial prescribing and support the reduction in unnecessary and/or ineffective use of antimicrobials, which in turn can help reduce the burden of antimicrobial resistance.
This policy brief highlights the impact of AMR and the challenges in countering the phenomenon. The brief provides recommendations on how to structure the approach to combat the spread of and fight antimicrobial resistance, namely by combining knowledge from an array of fields, including public-private collaborations, promoting and enhancing technology transfers, and more. Ultimately, it is essential that civil society continues to maintain the issue of AMR on the public agenda, at national, regional, and global levels.
Currently, most of the approaches to tackle AMR are focused on reducing the consumption of antibiotics. However, in this background paper, we discuss the importance of taking a One Health approach to AMR and why it is so necessary to better understand all of its drivers, including biological, agricultural, environmental and societal spheres.
This paper details a case study of a review of the national action plans (NAP) in Italy, the Netherlands and Spain. Its goal is to better understand the epidemiology related to AMR in the three countries. Then their NAPs are evaluated and compared. Finally, this paper formulates recommendations to improve the NAPs and their implementation. More effective NAPs will help tackle AMR in the EU.
The reported increase of AMR incidence in the Netherlands and the sheer numbers of annual deaths in the EU should be a matter of concern for everyone, and public authorities should address the issue as a fundamental threat to public health and welfare. This policy brief reviews the content of the existing NAP on AMR in the Netherlands to identify gaps and provide recommendations for future adaptations.